Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
COLLEGIUM PHARMACEUTICAL, INC | Director | Common Stock | 52.5 K | $1.69 M | $32.30 | May 16, 2024 | Direct |
Gain Therapeutics, Inc. | Director | Stock Option (right to buy) | 15 K | $87.9 K | $5.86 | Jun 24, 2024 | Direct |
SOLENO THERAPEUTICS INC | Director | Common Stock | 666 | $24.3 K | $36.49 | Aug 26, 2022 | Direct |
Protalix BioTherapeutics, Inc. | Director | Stock Options (Right to Buy) | 61.7 K | Sep 29, 2023 | Direct | ||
SOLENO THERAPEUTICS INC | Director | Stock option (right to buy) | 10 K | May 26, 2023 | Direct |